Deborah B Doroshow, MD, PhD
- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Ruttenberg Treatment Center 212-241-6756 212-241-6756
Dr. Doroshow is Assistant Professor of Medicine at the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai. She divides her clinical practice and research between the Early Phase Trials Unit, where she sees patients with a variety of solid tumors on phase 1 and 2 trials of novel agents, and the Center for Thoracic Oncology, where she sees patients with lung cancer. Her research focuses on the use of targeted therapies to treat cancer and examines the use of novel agents to target DNA damage and repair processes. She is passionate about her role as a guide to patients and families at a difficult time and making cancer less scary by talking about it in plain language. Clinical trials allow patients to try novel medications but can also be unfamiliar, and she is lucky to work with a team of clinicians who work to make the clinical trials process more accessible to patients.
Dr. Doroshow is also a historian of American medicine and holds a Ph.D. in history, which she uses to understand how social and cultural factors in the past and present play a role in patients’ experience of illness and treatment. Her book, Emotionally Disturbed: A History of Caring for America's Troubled Children, was published in April 2019 by the University of Chicago Press.
American Board of Internal Medicine
MD, Harvard Medical School
PhD, Yale University
Residency, Internal Medicine
Yale University School of Medicine
Yale University School of Medicine
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Doroshow did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.